Jeju, South Korea

Ki-Chang Jang

This inventor holds 3 USPTO granted patents. Top assignees: Korea Research Institute of Bioscience and Biotechnology, Korea Research Institute of Bioscience. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki-Chang Jang. Retrieved from https://idiyas.com/inventor/ki-chang-jang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Location History:

  • Jeju-si, KR (2009)
  • Jeju Province, KR (2010)

Company Filing History:


Years Active: 2009-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Inventor Ki-Chang Jang**

Introduction

Ki-Chang Jang, an inventive mind from Jeju Province, Korea, has made significant strides in the field of cardiovascular health through his innovative research. With a total of three patents to his name, Jang's work focuses on the discovery and application of unique compounds that can aid in the prevention and treatment of cardiovascular diseases.

Latest Patents

Jang's latest patents include a groundbreaking approach involving abietane diterpenoid compounds and compositions derived from Torreya nucifera. One notable patent outlines a method for treating cardiovascular conditions such as hyperlipidemia and atherosclerosis, utilizing a pharmaceutically effective amount of these compounds. The invention emphasizes the ability of the abietane diterpenoid compound to inhibit the oxidation of low-density lipoprotein (LDL) and also reduce the activity of acyl-CoA: cholesterol acyltransferase (ACAT), highlighting its potential as a therapeutic agent. Furthermore, the preparation of these extracts involves sophisticated methods using leaves, stems, or seeds processed with various solvents, ensuring a high-quality product for medicinal use.

Career Highlights

Throughout his career, Ki-Chang Jang has been associated with reputable institutions including the Korea Research Institute of Bioscience and Biotechnology and the Korea Research Institute of Bioscience. His contributions in these roles have propelled advancements in bioscience and biotechnology, particularly in the area of cardiovascular treatment.

Collaborations

Jang has collaborated with distinguished colleagues such as Tae-Sook Jeong and Woo-Song Lee, with whom he has shared insights and expertise to foster innovation in their research endeavors. These collaborations have not only enhanced the development of his patents but have also contributed to the collective effort of improving healthcare solutions.

Conclusion

Ki-Chang Jang stands out as a prominent inventor in the realm of cardiovascular innovations. His dedication to harnessing the power of natural compounds through his patents has the potential to significantly influence the treatment of cardiovascular diseases. As he continues to explore new frontiers in bioscience, Jang's work exemplifies the importance of innovative thinking in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…